Introduction: Mumps is a vaccine-preventable viral disease that may cause deafness, orchitis, encephalitis or death. However, mumps vaccine is not included in Zambia’s Expanded Program for Immunization. In January 2015, Integrated Disease Surveillance and Response data revealed an increase in reported mumps cases in Luanshya District. We investigated to confirm the etiology and generate epidemiological data on mumps in Zambia. Methods: We conducted active case finding, examined possible case-patients, and administered a standard questionnaire. A suspected mumps case was defined as acute onset of salivary gland swelling in a Luanshya resident during January June 2015. Eight case-patients provided serum samples to test for mumps-specific immunoglobulin IgM, and buccal swabs to test for mumps viral RNA by RT-PCR, and genotyping of mumps virus at the Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Results: From January – June 2015, a total of 283 mumps cases were reported in Luanshya, peaking in April (71 cases) and clustering (81%) in two townships. Of 72 suspected case-patients interviewed, 81% were aged < 15 years (29%, 1 4 years) and 61% were female. Common clinical characteristics were buccal tenderness (29%) and fever > 37.5oC (29%). Mumps virus genotype D was confirmed in five case-patients who tested positive by RT-PCR; six case-patients were sero-positive for anti-mumps IgM antibodies (total seven lab-confirmed cases). Conclusion: Our findings represent the first reported epidemiologic description of mumps in Zambia. While the epidemiology is consistent with prior descriptions of mumps in unimmunized populations and no serious complications arose, this report provides data to inform policy discussions regarding mumps vaccination in Zambia. Pan African Medical Journal. 2018; 31:3 doi:10.11604/pamj.2018.31.3.11720 This article is available online at: http://www.panafrican-med-journal.com/content/article/31/3/full/ © Ernest Kateule et al. The Pan African Medical Journal ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Pan African Medical Journal – ISSN: 19378688 (www.panafrican-med-journal.com) Published in partnership with the African Field Epidemiology Network (AFENET). (www.afenet.net) Research Open Access
[1]
R. Myers,et al.
Genomic diversity of mumps virus and global distribution of the 12 genotypes
,
2015,
Reviews in medical virology.
[2]
S. Park.
Resurgence of Mumps in Korea
,
2015,
Infection & chemotherapy.
[3]
John W. Glasser,et al.
Mumps resurgences in the United States: A historical perspective on unexpected elements.
,
2009,
Vaccine.
[4]
S. Rubin,et al.
Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks?
,
2008,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5]
Umesh Parashar,et al.
Recent resurgence of mumps in the United States.
,
2008,
The New England journal of medicine.
[6]
P. Rota,et al.
Proposal for genetic characterisation of wild-type mumps strains: Preliminary standardisation of the nomenclature
,
2005,
Archives of Virology.
[7]
D. Brown,et al.
Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes.
,
1999,
The Journal of infectious diseases.
[8]
W. Bellini,et al.
Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays
,
1992,
Journal of clinical microbiology.
[9]
J. Chin.
Mumps vaccine
,
1967,
California medicine.
[10]
A. Galazka,et al.
Mumps and mumps vaccine: A global review
,
1999,
Bulletin of the World Health Organization.